WALTHAM, Mass.--(BUSINESS WIRE)--Glytec President and CEO, Bob Leonard, will present an update on the company at the 29th Annual Piper Jaffray Healthcare Conference, Wednesday, November 29, 2017, 3:00 pm EST. The invitation-only event is being held in New York City at the Lotte New York Palace Hotel.
Founded in 2006, Glytec is the pioneer of personalized digital therapeutics. The company’s patented, FDA-cleared software-as-a-device solution is proven to improve the safety and health of people with diabetes in the hospital and at home. Glytec’s cloud-hosted eGlycemic Management System® enables health systems, payers and patients to address the complexities of insulin management that commonly frustrate providers and compromise outcomes for millions of people living with diabetes. Glytec combines interventional clinical decision support technologies and expert clinical services to optimize insulin therapy and in turn reduce complications, drug waste, adverse drug events, mortality, avoidable ED visits and hospitalizations, and readmissions. For more information visit www.glytecsystems.com.